Abstract

Despite the many claims made (see Medical Letter, Brit. ed. 1962, 1, 38), androgens and the anabolic steroids related to them have been shown to be of value only in male hypogonadism, in breast cancer in women after the menopause and in some patients with myelofibrosis and aplastic anaemia.